Search research articles
Contact Us
Filters
Showing results (261-270 of 274) with videos related to
Page
of 28
Sort By:
Recent Progress in Hormone Research
|
January 1, 1986
Physiological and clinical studies of GRF and GH
M O Thorner, M L Vance, W S Evans, et al.
Acta Neurochirurgica
|
January 1, 1985
Human pancreatic tumor GH-releasing factor
M O Thorner, W S Evans, M Vance, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 1997
Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults
I M Chapman, O H Pescovitz, G Murphy, et al.
Transactions of the Association of American Physicians
|
January 1, 1982
Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor
M O Thorner, R L Perryman, M J Cronin, et al.
British Medical Journal
|
July 12, 1975
Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone
D Carr, A Gomez-Pan, D R Weightman, et al.
Lancet (London, England)
|
May 31, 1975
Letter: Analogues of growth-hormone release-inhibiting hormone
D C Evered, A Gomez-Pan, W M Tunbridge, et al.
Lancet (London, England)
|
November 9, 1974
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone
S R Bloom, C H Mortimer, M O Thorner, et al.
British Medical Journal
|
December 14, 1974
Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones
G M Besser, C H Mortimer, A S McNeilly, et al.
Lancet (London, England)
|
January 1, 1983
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man
M O Thorner, J Rivier, J Spiess, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1996
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects
I M Chapman, M A Bach, E Van Cauter, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 274) with videos related to
Sort By:
Page
of 28
Recent Progress in Hormone Research
|
January 1, 1986
Physiological and clinical studies of GRF and GH
M O Thorner, M L Vance, W S Evans, et al.
Acta Neurochirurgica
|
January 1, 1985
Human pancreatic tumor GH-releasing factor
M O Thorner, W S Evans, M Vance, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 1997
Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults
I M Chapman, O H Pescovitz, G Murphy, et al.
Transactions of the Association of American Physicians
|
January 1, 1982
Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor
M O Thorner, R L Perryman, M J Cronin, et al.
British Medical Journal
|
July 12, 1975
Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone
D Carr, A Gomez-Pan, D R Weightman, et al.
Lancet (London, England)
|
May 31, 1975
Letter: Analogues of growth-hormone release-inhibiting hormone
D C Evered, A Gomez-Pan, W M Tunbridge, et al.
Lancet (London, England)
|
November 9, 1974
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone
S R Bloom, C H Mortimer, M O Thorner, et al.
British Medical Journal
|
December 14, 1974
Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones
G M Besser, C H Mortimer, A S McNeilly, et al.
Lancet (London, England)
|
January 1, 1983
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man
M O Thorner, J Rivier, J Spiess, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1996
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects
I M Chapman, M A Bach, E Van Cauter, et al.
Page
of 28